EZR

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA021616

Antibody CAB004035

Antibody CAB047324

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant cells showed moderate to strong cytoplasmic and occasional membranous immunoreactivity. Hepatocellular carcinomas were negative. A majority of malignant cells displayed moderate to strong cytoplasmic and membranous immunoreactivity. Strongest staining was found in malignant lymphomas and breast cancers. Most malignant cells displayed moderate to strong cytoplasmic immunoreactivity with additional membranous staining in several cases. Several cases of malignant gliomas were negative.

Literature conformity

Consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected